Machine learning-based prediction of diabetic patients using blood routine data
Methods · 2024
DOI: 10.1016/j.ymeth.2024.07.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods, 2024. Verfasst von Honghao Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: Machine Learning, Diabetes Mellitus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Diabetes stands as one of the most prevalent chronic diseases globally. The conventional methods for diagnosing diabetes are frequently overlooked until individuals manifest noticeable symptoms of the condition. This study aimed to address this gap by collecting comprehensive datasets, including 1000 instances of blood routine data from diabetes patients and an equivalent dataset from healthy individuals. To differentiate diabetes patients from their healthy counterparts, a computational framework was established, encompassing eXtreme Gradient Boosting (XGBoost), random forest, support vector machine, and elastic net algorithms. Notably, the XGBoost model emerged as the most effective, exhibiting superior predictive results with an area under the receiver operating characteristic curve (AUC) of 99.90% in the training set and 98.51% in the testing set. Moreover, the model showcased commendable performance during external validation, achieving an overall accuracy of 81.54%. The probability generated by the model serves as a risk score for diabetes susceptibility. Further interpretability was achieved through the utilization of the Shapley additive explanations (SHAP) algorithm, identifying pivotal indicators such as mean corpuscular hemoglobin concentration (MCHC), lymphocyte ratio (LY%), standard deviation of red blood cell distribution width (RDW-SD), and mean corpuscular hemoglobin (MCH). This enhances our understanding of the predictive mechanisms underlying diabetes. To facilitate the application in clinical and real-life settings, a nomogram was created based on the logistic regression algorithm, which can provide a preliminary assessment of the likelihood of an individual having diabetes. Overall, this research contributes valuable insights into the predictive modeling of diabetes, offering potential applications in clinical practice for more effective and timely diagnoses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
- Biotechnology Experimental Center, Harbin Medical University, Harbin 150081, China.
- The State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, College of Life Sciences, Inner Mongolia University, Hohhot 010070, China.
- The State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, College of Life Sciences, Inner Mongolia University, Hohhot 010070, China; Inner Mongolia International Mongolian Hospital, Hohhot…
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China. Electronic address: leiyang@hrbmu.edu.cn.
Zitieren
APA
Li, H., Su, D., Zhang, X., He, Y., Luo, X., Xiong, Y., Zou, M., Wei, H., Wen, S., Xi, Q., Zuo, Y., & Yang, L. (2024). Machine learning-based prediction of diabetic patients using blood routine data. Methods. https://doi.org/10.1016/j.ymeth.2024.07.001
Vancouver
Li H, Su D, Zhang X, He Y, Luo X, Xiong Y, et al. Machine learning-based prediction of diabetic patients using blood routine data. Methods. 2024. doi:10.1016/j.ymeth.2024.07.001
BibTeX
@article{Li2024,
author = {Li, Honghao and Su, Dongqing and Zhang, Xinpeng and He, Yuanyuan and Luo, Xu and Xiong, Yuqiang and Zou, Min and Wei, Huiyan and Wen, Shaoran and Xi, Qilemuge and Zuo, Yongchun and Yang, Lei},
title = {Machine learning-based prediction of diabetic patients using blood routine data},
journal = {Methods},
year = {2024},
doi = {10.1016/j.ymeth.2024.07.001}
}
EUVIMED